Casey Romano, NP
Women's Health · San Francisco, CANPI 1285981449
Payments from drug & device makers
Across 46 payments — averaging $22.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$298
- Hologic Sales And Service, LLC$116
- Evofem Biosciences, Inc.$110
- Organon$75
- Myriad Women's Health, Inc.$59
- Therapeuticsmd, Inc.$37
- plus $322 from 15 others
What the payments were for
- Food & beverage$1,017100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $298 |
| Hologic Sales And Service, LLC | 4 | $116 |
| Evofem Biosciences, Inc. | 6 | $110 |
| Organon | 4 | $75 |
| Myriad Women's Health, Inc. | 1 | $59 |
| Therapeuticsmd, Inc. | 2 | $37 |
| Amgen | 2 | $37 |
| Scynexis, Inc. | 1 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| Exact Sciences | 1 | $25 |
| Roche Diagnostics Corporation | 1 | $24 |
| Medtronic | 1 | $21 |
| Avanos Medical | 1 | $21 |
| Davol Inc. | 1 | $20 |
| Octapharma USA, Inc. | 1 | $19 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| Medicem Inc. | 1 | $15 |
| Aspira Women's Health Inc | 1 | $15 |
How this compares
$1,017 in reported general payments places this provider in the 80th percentile of 480 women's health providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 21 | $2,037 |
Paid to pharmacies, not to this prescriber.
Other women's health in San Francisco
- Barbara DehnMountain View$87K
- Zaruhi HarutyunyanWest Hollywood$55K
- Roberta MoradfarWest Hollywood$30K
- Patricia GeraghtyWalnut Creek$26K
- Katherine KetzStockton$26K
- Maggie WangRowland Heights$23K
- Debbie BarishBerkeley$16K
- Raisa HowardEl Segundo$11K
- Mary FesselWoodland$8K
- Kay MorelandSanta Maria$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.